Monoclonal antibodies (MAbs) which recognize a human tumor antigen, termed tumor-associated glycoprotein-72 (TAG-72), have successfully been used to localize primary as well as metastatic colorectal tumor lesions in patients. The localization of the anti-TAG-72 MAbs has also been exploited intraoper
Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma
โ Scribed by Toshio Takahashi; Toshiharu Yamaguchi; Kazuya Kitamura; Hiroshi Suzuyama; Mitsuyo Honda; Takashi Yokota; Hitoshi Kotanagi; Masahiro Takahashi; Yoshiyuki Hashimoto
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 902 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Rhenium-186 (186re) has ideal properties for adjuvant radioimmunotherapy (rit). however, the lack of suitable methods for high dose 186re labeling of monoclonal antibodies (mabs) has hampered the use of 186re in clinical rit. after development of a chemically identical multistep proc
At present, tumor-targeting with monoclonal antibodies ( M U ) is among the most promising novel adjuvant-therapy modalities for the treatment of patients with minimal residual disease of head-and-neck squamous-cell carcinoma (HNSCC For this purpose we developed MAb U36, recognizing a 2 d kDa antige